Evidence map›Paper›PMID 40665312›Full record

ArticleBMC medical informatics and decision making2025

Predicting individual hemoglobin abnormalities using longitudinal data in clinical practice.

Maliheh Namazkhan, Karel Jan van Tuijn, Maurits Kaptein, Remco van Horssen

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maliheh NamazkhanDepartment of Methodology and Statistics, Tilburg School of Social and Behavioral Sciences, University of Tilburg, Tilburg, The Netherlands. m.namazkhan@tilburguniversity.edu.
Karel Jan van TuijnHealth Center Pannenhoef, General Practitioner, Kaatsheuvel, The Netherlands.
Maurits KapteinDepartment of Mathematics and Computer Science, Eindhoven University of Technology, Eindhoven, The Netherlands.
Remco van HorssenDepartment of Clinical Chemistry and Hematology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn preventive medicine, the promotion of health and well-being through early detection and intervention is crucial to preventing the development of diseases. This study aims to predict potential abnormalities in hemoglobin levels before they occur, using individualised observations within normal ranges.

methodsWe utilise a dataset generated over seven years, comprising 30,000 patients. Multiple prediction models are employed to identify hemoglobin trends within individuals and predict their next-to-measure hemoglobin value based on past measurements. We focus on whether, at a specific point in time, the individual's values are likely to run outside of the individual 'normal' bounds. A Generalised Additive Model is explored as a plausible approach for predicting future individual hemoglobin values. By calculating confidence intervals for predicted hemoglobin values, we evaluate prediction uncertainty, while assessing the percentage of accurate predictions within these intervals to gauge the reliability of our model's prediction.

resultsWe find that for 88.47% of the cases, our model accurately predicts whether patients' hemoglobin levels will stay within individual 'normal' bounds or deviate from them, demonstrating its effectiveness in identifying 'out-of-normal' measurements.

conclusionsThe findings hold practical significance, potentially reducing unnecessary blood draws and preventing the onset of abnormal hemoglobin levels through preventive healthcare interventions or digital lifestyle coaching. Moreover, early detection and intervention can significantly impact individual patients by preventing disease development.

Indexed as

HemoglobinopathiesHemoglobinsFemaleHumansLongitudinal StudiesMaleMiddle AgedHemoglobinsGeneralised additive modelIndividual hemoglobin valueLongitudinal dataPrediction modelPreventive health

Identifiers

PMID40665312
PMCPMC12261692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.